I still stand by my belief that the interim analysis results released before end of march will be HUGE. Until then, I don't think much will happen. MSB tends to go down in absence of announcements. I listened to one of the webcasts last night (not sure which one), but Silviu said something along the lines of how positive interim analysis results will be used to get fast track product approval under the cures act and also to get another Partnership (possibly Celgene).
But until end of March we are just waiting.
I still stand by my belief that the interim analysis results...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $14.57M | 13.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21024 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 241 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |